| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Equity | 26 | 2025 | 110 | 11.220 |
Why?
|
| Healthcare Disparities | 50 | 2024 | 528 | 9.250 |
Why?
|
| Diabetes Mellitus | 56 | 2024 | 800 | 8.050 |
Why?
|
| Delivery of Health Care | 23 | 2026 | 474 | 5.150 |
Why?
|
| Community Health Centers | 25 | 2016 | 119 | 4.860 |
Why?
|
| Racism | 7 | 2024 | 106 | 4.470 |
Why?
|
| Patient-Centered Care | 16 | 2022 | 228 | 4.080 |
Why?
|
| Quality of Health Care | 22 | 2026 | 386 | 3.310 |
Why?
|
| Attitude of Health Personnel | 25 | 2022 | 671 | 3.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 27 | 2023 | 1260 | 3.130 |
Why?
|
| Safety-net Providers | 10 | 2019 | 46 | 2.690 |
Why?
|
| Health Status Disparities | 13 | 2024 | 232 | 2.530 |
Why?
|
| United States | 92 | 2026 | 7976 | 2.450 |
Why?
|
| Humans | 264 | 2026 | 96382 | 2.370 |
Why?
|
| Students, Medical | 5 | 2024 | 446 | 2.330 |
Why?
|
| Quality Assurance, Health Care | 16 | 2014 | 227 | 2.320 |
Why?
|
| Quality Improvement | 18 | 2023 | 510 | 2.240 |
Why?
|
| Insurance, Health | 11 | 2023 | 183 | 2.210 |
Why?
|
| Health Personnel | 7 | 2022 | 251 | 2.130 |
Why?
|
| Patient Participation | 9 | 2019 | 244 | 1.960 |
Why?
|
| Self Care | 13 | 2019 | 187 | 1.930 |
Why?
|
| Health Care Reform | 4 | 2021 | 77 | 1.830 |
Why?
|
| Chronic Disease | 14 | 2023 | 970 | 1.830 |
Why?
|
| Health Policy | 9 | 2026 | 214 | 1.820 |
Why?
|
| Health Services Accessibility | 15 | 2025 | 515 | 1.790 |
Why?
|
| Primary Health Care | 15 | 2025 | 389 | 1.750 |
Why?
|
| Decision Making | 10 | 2020 | 683 | 1.720 |
Why?
|
| Physician-Patient Relations | 13 | 2023 | 574 | 1.670 |
Why?
|
| Diabetes Complications | 13 | 2015 | 175 | 1.590 |
Why?
|
| Social Justice | 5 | 2025 | 62 | 1.550 |
Why?
|
| Physicians | 15 | 2016 | 680 | 1.510 |
Why?
|
| Religion and Medicine | 10 | 2014 | 121 | 1.480 |
Why?
|
| Community Health Services | 7 | 2014 | 79 | 1.470 |
Why?
|
| Ambulatory Care Facilities | 6 | 2017 | 120 | 1.450 |
Why?
|
| Sexual and Gender Minorities | 6 | 2020 | 258 | 1.440 |
Why?
|
| Minority Groups | 8 | 2024 | 155 | 1.440 |
Why?
|
| Patient Education as Topic | 17 | 2019 | 406 | 1.320 |
Why?
|
| Prejudice | 7 | 2021 | 51 | 1.270 |
Why?
|
| Medicaid | 10 | 2024 | 271 | 1.260 |
Why?
|
| Male | 119 | 2025 | 46116 | 1.260 |
Why?
|
| Cross-Sectional Studies | 30 | 2024 | 1981 | 1.260 |
Why?
|
| Female | 122 | 2025 | 50528 | 1.210 |
Why?
|
| Trust | 3 | 2023 | 104 | 1.210 |
Why?
|
| Quality Indicators, Health Care | 7 | 2020 | 153 | 1.170 |
Why?
|
| Heart Failure | 16 | 2024 | 1460 | 1.170 |
Why?
|
| Health Status | 13 | 2017 | 382 | 1.170 |
Why?
|
| Medical Informatics | 2 | 2022 | 50 | 1.160 |
Why?
|
| Insurance Coverage | 7 | 2023 | 150 | 1.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2015 | 581 | 1.120 |
Why?
|
| Health Promotion | 6 | 2023 | 176 | 1.110 |
Why?
|
| Machine Learning | 3 | 2022 | 377 | 1.100 |
Why?
|
| Delivery of Health Care, Integrated | 4 | 2017 | 70 | 1.090 |
Why?
|
| Adult | 72 | 2025 | 28968 | 1.070 |
Why?
|
| Health Care Surveys | 15 | 2017 | 281 | 1.060 |
Why?
|
| Health Services Needs and Demand | 4 | 2019 | 100 | 1.060 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2024 | 188 | 1.030 |
Why?
|
| Social Responsibility | 3 | 2025 | 53 | 1.020 |
Why?
|
| Surveys and Questionnaires | 27 | 2024 | 2951 | 1.000 |
Why?
|
| Aged | 66 | 2023 | 21309 | 0.990 |
Why?
|
| Reimbursement, Incentive | 6 | 2018 | 36 | 0.990 |
Why?
|
| Chicago | 24 | 2018 | 1488 | 0.990 |
Why?
|
| Blood Glucose | 9 | 2021 | 901 | 0.950 |
Why?
|
| Middle Aged | 71 | 2025 | 28794 | 0.940 |
Why?
|
| Burnout, Professional | 4 | 2019 | 121 | 0.940 |
Why?
|
| Social Support | 7 | 2023 | 244 | 0.920 |
Why?
|
| Population Health | 2 | 2023 | 35 | 0.920 |
Why?
|
| Job Satisfaction | 3 | 2019 | 84 | 0.900 |
Why?
|
| Socioeconomic Factors | 12 | 2023 | 652 | 0.900 |
Why?
|
| Residence Characteristics | 7 | 2019 | 224 | 0.890 |
Why?
|
| Health Expenditures | 4 | 2020 | 100 | 0.870 |
Why?
|
| Curriculum | 7 | 2023 | 615 | 0.870 |
Why?
|
| Program Evaluation | 12 | 2018 | 336 | 0.840 |
Why?
|
| Internal Medicine | 8 | 2008 | 331 | 0.840 |
Why?
|
| Public Health | 3 | 2022 | 158 | 0.830 |
Why?
|
| Quality of Life | 12 | 2023 | 1869 | 0.830 |
Why?
|
| Patient Care Management | 3 | 2010 | 29 | 0.820 |
Why?
|
| Morale | 4 | 2019 | 16 | 0.810 |
Why?
|
| Health Behavior | 8 | 2015 | 198 | 0.790 |
Why?
|
| Spirituality | 6 | 2007 | 88 | 0.790 |
Why?
|
| Endocrine System Diseases | 2 | 2021 | 25 | 0.790 |
Why?
|
| Health Services Research | 14 | 2023 | 144 | 0.790 |
Why?
|
| Students, Health Occupations | 1 | 2023 | 5 | 0.780 |
Why?
|
| Education, Medical | 2 | 2023 | 229 | 0.780 |
Why?
|
| Patient Satisfaction | 10 | 2017 | 509 | 0.770 |
Why?
|
| Organizational Innovation | 3 | 2019 | 40 | 0.770 |
Why?
|
| Language | 2 | 2015 | 164 | 0.760 |
Why?
|
| Drama | 1 | 2022 | 7 | 0.760 |
Why?
|
| Program Development | 10 | 2017 | 138 | 0.760 |
Why?
|
| Renal Dialysis | 2 | 2017 | 355 | 0.730 |
Why?
|
| Community Networks | 2 | 2014 | 37 | 0.730 |
Why?
|
| Hospitalization | 10 | 2024 | 963 | 0.710 |
Why?
|
| Drug Costs | 1 | 2022 | 65 | 0.710 |
Why?
|
| Awards and Prizes | 1 | 2022 | 37 | 0.700 |
Why?
|
| Models, Organizational | 5 | 2016 | 47 | 0.690 |
Why?
|
| Health Plan Implementation | 5 | 2018 | 62 | 0.690 |
Why?
|
| Religion | 4 | 2007 | 90 | 0.680 |
Why?
|
| Total Quality Management | 3 | 2010 | 31 | 0.670 |
Why?
|
| Algorithms | 5 | 2023 | 1974 | 0.670 |
Why?
|
| Ethicists | 1 | 2020 | 20 | 0.660 |
Why?
|
| Ethics Consultation | 1 | 2020 | 13 | 0.650 |
Why?
|
| Patient Care | 1 | 2021 | 100 | 0.640 |
Why?
|
| Hospitals | 3 | 2023 | 334 | 0.640 |
Why?
|
| Leadership | 4 | 2023 | 154 | 0.630 |
Why?
|
| Hypertension | 7 | 2022 | 763 | 0.630 |
Why?
|
| Professional-Patient Relations | 4 | 2016 | 48 | 0.610 |
Why?
|
| Practice Patterns, Physicians' | 7 | 2015 | 649 | 0.600 |
Why?
|
| Peer Group | 2 | 2012 | 97 | 0.600 |
Why?
|
| Teaching | 1 | 2020 | 140 | 0.600 |
Why?
|
| Palliative Care | 2 | 2020 | 280 | 0.590 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 396 | 0.580 |
Why?
|
| Urban Population | 7 | 2011 | 243 | 0.580 |
Why?
|
| Continuity of Patient Care | 2 | 2017 | 176 | 0.580 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 122 | 0.580 |
Why?
|
| Aged, 80 and over | 29 | 2019 | 7277 | 0.580 |
Why?
|
| Epilepsy | 1 | 2023 | 445 | 0.580 |
Why?
|
| Research Support as Topic | 4 | 2011 | 93 | 0.570 |
Why?
|
| Health Services for the Aged | 3 | 2006 | 32 | 0.550 |
Why?
|
| Medically Uninsured | 6 | 2016 | 71 | 0.550 |
Why?
|
| Cardiovascular Diseases | 7 | 2021 | 785 | 0.520 |
Why?
|
| Catholicism | 3 | 2015 | 46 | 0.510 |
Why?
|
| Reimbursement Mechanisms | 1 | 2017 | 40 | 0.510 |
Why?
|
| Midwestern United States | 8 | 2014 | 91 | 0.510 |
Why?
|
| Exercise | 7 | 2015 | 373 | 0.510 |
Why?
|
| Cooperative Behavior | 7 | 2018 | 199 | 0.510 |
Why?
|
| Adolescent | 22 | 2022 | 9948 | 0.500 |
Why?
|
| Poverty Areas | 5 | 2020 | 37 | 0.490 |
Why?
|
| Poverty | 2 | 2017 | 212 | 0.490 |
Why?
|
| Organ Transplantation | 1 | 2020 | 304 | 0.480 |
Why?
|
| Social Environment | 1 | 2017 | 198 | 0.480 |
Why?
|
| Vulnerable Populations | 5 | 2014 | 95 | 0.480 |
Why?
|
| Health | 2 | 2007 | 27 | 0.480 |
Why?
|
| Bisexuality | 1 | 2016 | 36 | 0.470 |
Why?
|
| Health Care Costs | 5 | 2012 | 252 | 0.470 |
Why?
|
| Qualitative Research | 9 | 2023 | 391 | 0.470 |
Why?
|
| Specialization | 3 | 2008 | 69 | 0.470 |
Why?
|
| Electronic Health Records | 2 | 2022 | 412 | 0.470 |
Why?
|
| Cultural Competency | 2 | 2022 | 23 | 0.460 |
Why?
|
| Activities of Daily Living | 6 | 2005 | 214 | 0.460 |
Why?
|
| Young Adult | 14 | 2024 | 7318 | 0.450 |
Why?
|
| Kidney Failure, Chronic | 2 | 2017 | 445 | 0.450 |
Why?
|
| Emergency Service, Hospital | 6 | 2024 | 613 | 0.440 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 412 | 0.440 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 32 | 0.430 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2016 | 263 | 0.430 |
Why?
|
| Medicare Part C | 1 | 2014 | 7 | 0.430 |
Why?
|
| Precision Medicine | 2 | 2016 | 484 | 0.430 |
Why?
|
| Documentation | 1 | 2015 | 104 | 0.420 |
Why?
|
| Motivation | 6 | 2018 | 334 | 0.420 |
Why?
|
| Interviews as Topic | 10 | 2019 | 374 | 0.420 |
Why?
|
| Drug Utilization Review | 3 | 1999 | 14 | 0.420 |
Why?
|
| Communication | 6 | 2023 | 450 | 0.410 |
Why?
|
| Patient Care Team | 5 | 2019 | 315 | 0.410 |
Why?
|
| Focus Groups | 6 | 2019 | 208 | 0.410 |
Why?
|
| Mexican Americans | 1 | 2014 | 70 | 0.400 |
Why?
|
| Attitude to Health | 6 | 2016 | 217 | 0.400 |
Why?
|
| Cardiology | 4 | 2009 | 121 | 0.390 |
Why?
|
| Obesity | 6 | 2019 | 1044 | 0.380 |
Why?
|
| Cultural Diversity | 5 | 2021 | 64 | 0.380 |
Why?
|
| Logistic Models | 11 | 2014 | 1270 | 0.370 |
Why?
|
| Health Facility Administrators | 5 | 2015 | 15 | 0.360 |
Why?
|
| Academic Medical Centers | 4 | 2018 | 408 | 0.360 |
Why?
|
| Preventive Health Services | 3 | 2022 | 38 | 0.350 |
Why?
|
| Referral and Consultation | 4 | 2011 | 400 | 0.350 |
Why?
|
| Smoking Cessation | 1 | 2015 | 302 | 0.350 |
Why?
|
| Medical Errors | 2 | 2009 | 93 | 0.350 |
Why?
|
| Databases, Factual | 1 | 2016 | 1069 | 0.350 |
Why?
|
| Bias | 2 | 2022 | 138 | 0.340 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 2764 | 0.340 |
Why?
|
| Medicare | 5 | 2020 | 463 | 0.340 |
Why?
|
| Risk Reduction Behavior | 3 | 2008 | 101 | 0.340 |
Why?
|
| Patient Preference | 1 | 2012 | 132 | 0.330 |
Why?
|
| Overweight | 2 | 2011 | 122 | 0.330 |
Why?
|
| Child Health Services | 1 | 2011 | 35 | 0.330 |
Why?
|
| Geriatrics | 3 | 2003 | 67 | 0.330 |
Why?
|
| Family Health | 1 | 2011 | 156 | 0.320 |
Why?
|
| Medical Informatics Applications | 1 | 2010 | 8 | 0.320 |
Why?
|
| Multivariate Analysis | 10 | 2017 | 1007 | 0.320 |
Why?
|
| Managed Care Programs | 2 | 2023 | 37 | 0.320 |
Why?
|
| Ethics, Medical | 3 | 2007 | 291 | 0.320 |
Why?
|
| Behavior Therapy | 1 | 2011 | 100 | 0.310 |
Why?
|
| School Admission Criteria | 1 | 2010 | 30 | 0.310 |
Why?
|
| Motor Activity | 2 | 2008 | 328 | 0.290 |
Why?
|
| Sexual Behavior | 2 | 2020 | 338 | 0.290 |
Why?
|
| Emigrants and Immigrants | 1 | 2009 | 46 | 0.290 |
Why?
|
| Government Regulation | 1 | 2009 | 49 | 0.290 |
Why?
|
| Safety Management | 1 | 2009 | 53 | 0.290 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 1997 | 98 | 0.280 |
Why?
|
| Prevalence | 7 | 2020 | 1362 | 0.280 |
Why?
|
| Life Style | 3 | 2006 | 189 | 0.280 |
Why?
|
| Safety | 1 | 2009 | 138 | 0.280 |
Why?
|
| Directive Counseling | 1 | 2008 | 34 | 0.270 |
Why?
|
| Emergency Medical Services | 2 | 2003 | 279 | 0.270 |
Why?
|
| Child | 12 | 2024 | 7540 | 0.270 |
Why?
|
| Social Identification | 1 | 2008 | 29 | 0.270 |
Why?
|
| Costs and Cost Analysis | 3 | 2022 | 155 | 0.270 |
Why?
|
| Comorbidity | 9 | 2015 | 1027 | 0.270 |
Why?
|
| Medicine | 3 | 2008 | 95 | 0.270 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2007 | 164 | 0.260 |
Why?
|
| Health Facilities | 3 | 2021 | 43 | 0.260 |
Why?
|
| Feedback | 2 | 2020 | 131 | 0.260 |
Why?
|
| Evidence-Based Practice | 2 | 2018 | 53 | 0.260 |
Why?
|
| Professional Practice Location | 1 | 2007 | 6 | 0.260 |
Why?
|
| Professional Role | 1 | 2007 | 40 | 0.260 |
Why?
|
| Research | 4 | 2005 | 256 | 0.260 |
Why?
|
| Foundations | 3 | 2012 | 15 | 0.260 |
Why?
|
| Models, Psychological | 3 | 2008 | 165 | 0.250 |
Why?
|
| Models, Theoretical | 3 | 2017 | 500 | 0.250 |
Why?
|
| Myocardial Infarction | 3 | 2003 | 387 | 0.250 |
Why?
|
| Bariatric Surgery | 2 | 2007 | 210 | 0.250 |
Why?
|
| Community-Based Participatory Research | 3 | 2019 | 39 | 0.250 |
Why?
|
| Health Communication | 2 | 2017 | 15 | 0.250 |
Why?
|
| Parents | 2 | 2022 | 315 | 0.250 |
Why?
|
| Prospective Studies | 15 | 2015 | 4742 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2012 | 677 | 0.250 |
Why?
|
| Disease Management | 3 | 2019 | 370 | 0.250 |
Why?
|
| Patient Compliance | 4 | 2020 | 244 | 0.250 |
Why?
|
| Social Determinants of Health | 4 | 2022 | 124 | 0.240 |
Why?
|
| Maryland | 2 | 2023 | 45 | 0.240 |
Why?
|
| Pandemics | 2 | 2023 | 905 | 0.240 |
Why?
|
| Cohort Studies | 7 | 2023 | 3157 | 0.240 |
Why?
|
| Diet, Reducing | 1 | 2006 | 28 | 0.230 |
Why?
|
| Primary Prevention | 2 | 2006 | 90 | 0.230 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 92 | 0.230 |
Why?
|
| Pilot Projects | 5 | 2016 | 962 | 0.220 |
Why?
|
| Chi-Square Distribution | 4 | 2014 | 360 | 0.220 |
Why?
|
| Hawaii | 2 | 2023 | 27 | 0.220 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 169 | 0.220 |
Why?
|
| Data Collection | 5 | 2012 | 375 | 0.220 |
Why?
|
| Prisoners | 1 | 2025 | 48 | 0.220 |
Why?
|
| Self-Assessment | 1 | 2005 | 45 | 0.220 |
Why?
|
| Practice Management, Medical | 2 | 2014 | 20 | 0.220 |
Why?
|
| Radiometry | 1 | 2025 | 64 | 0.220 |
Why?
|
| Mortality | 3 | 2016 | 159 | 0.210 |
Why?
|
| Goals | 1 | 2005 | 68 | 0.210 |
Why?
|
| Geriatric Assessment | 3 | 2013 | 193 | 0.210 |
Why?
|
| Interprofessional Relations | 2 | 2020 | 120 | 0.210 |
Why?
|
| Health Facility Closure | 1 | 2024 | 8 | 0.210 |
Why?
|
| Decision Support Techniques | 2 | 2008 | 193 | 0.210 |
Why?
|
| Morals | 2 | 2020 | 103 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 6 | 2010 | 514 | 0.200 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 248 | 0.200 |
Why?
|
| Family Practice | 3 | 2000 | 72 | 0.200 |
Why?
|
| Academies and Institutes | 1 | 2023 | 35 | 0.200 |
Why?
|
| Interinstitutional Relations | 3 | 2018 | 29 | 0.200 |
Why?
|
| Needs Assessment | 3 | 2002 | 171 | 0.200 |
Why?
|
| New Zealand | 2 | 2025 | 23 | 0.200 |
Why?
|
| Choice Behavior | 1 | 2005 | 162 | 0.200 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2025 | 194 | 0.200 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2003 | 33 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 157 | 0.190 |
Why?
|
| Propensity Score | 1 | 2024 | 205 | 0.190 |
Why?
|
| Depression | 3 | 2021 | 592 | 0.190 |
Why?
|
| Rheumatoid Nodule | 1 | 2003 | 1 | 0.190 |
Why?
|
| Community-Institutional Relations | 2 | 2015 | 32 | 0.190 |
Why?
|
| Patient Selection | 1 | 2007 | 714 | 0.190 |
Why?
|
| Endocrinology | 2 | 2000 | 51 | 0.190 |
Why?
|
| Aging | 1 | 2008 | 757 | 0.190 |
Why?
|
| Clinical Competence | 2 | 1999 | 838 | 0.190 |
Why?
|
| Insurance | 1 | 2022 | 11 | 0.190 |
Why?
|
| Community Health Workers | 1 | 2023 | 38 | 0.180 |
Why?
|
| Socialization | 1 | 2022 | 13 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1759 | 0.180 |
Why?
|
| Text Messaging | 2 | 2012 | 35 | 0.180 |
Why?
|
| Advisory Committees | 1 | 2022 | 94 | 0.180 |
Why?
|
| Medical History Taking | 1 | 2022 | 81 | 0.170 |
Why?
|
| Rural Population | 1 | 2023 | 184 | 0.170 |
Why?
|
| Regression Analysis | 4 | 2013 | 580 | 0.170 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 41 | 0.170 |
Why?
|
| Tape Recording | 2 | 2012 | 15 | 0.170 |
Why?
|
| Health Status Indicators | 1 | 2002 | 99 | 0.170 |
Why?
|
| Health Care Rationing | 2 | 2018 | 84 | 0.170 |
Why?
|
| Intellectual Disability | 1 | 2022 | 200 | 0.170 |
Why?
|
| Diet | 4 | 2015 | 467 | 0.170 |
Why?
|
| Patient Outcome Assessment | 2 | 2018 | 90 | 0.170 |
Why?
|
| Long-Term Care | 1 | 2021 | 65 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2023 | 9526 | 0.170 |
Why?
|
| Alcoholism | 2 | 2000 | 193 | 0.170 |
Why?
|
| Feasibility Studies | 5 | 2019 | 792 | 0.160 |
Why?
|
| Stereotyping | 2 | 2016 | 20 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 208 | 0.160 |
Why?
|
| Empathy | 1 | 2022 | 153 | 0.160 |
Why?
|
| Sick Role | 1 | 2000 | 13 | 0.160 |
Why?
|
| Financing, Organized | 1 | 2020 | 13 | 0.160 |
Why?
|
| Gender Identity | 1 | 2020 | 58 | 0.160 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 26 | 0.160 |
Why?
|
| Emergencies | 2 | 2003 | 122 | 0.160 |
Why?
|
| Psychiatry | 3 | 2007 | 92 | 0.160 |
Why?
|
| Patient Advocacy | 2 | 2017 | 65 | 0.160 |
Why?
|
| Culture | 2 | 2019 | 57 | 0.150 |
Why?
|
| Sickness Impact Profile | 1 | 1999 | 29 | 0.150 |
Why?
|
| Population Surveillance | 2 | 2005 | 218 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2013 | 889 | 0.150 |
Why?
|
| Medication Errors | 1 | 1999 | 36 | 0.150 |
Why?
|
| Organizational Culture | 2 | 2016 | 33 | 0.150 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 1999 | 1 | 0.150 |
Why?
|
| Self-Management | 1 | 2019 | 48 | 0.150 |
Why?
|
| Dental Implantation, Endosseous | 1 | 1999 | 12 | 0.150 |
Why?
|
| Outpatients | 3 | 2009 | 105 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2021 | 456 | 0.150 |
Why?
|
| Age Factors | 3 | 2015 | 1957 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2019 | 3905 | 0.140 |
Why?
|
| Guideline Adherence | 3 | 2008 | 248 | 0.140 |
Why?
|
| Osteogenesis, Distraction | 1 | 1999 | 29 | 0.140 |
Why?
|
| Dental Plaque | 1 | 1998 | 2 | 0.140 |
Why?
|
| Social Class | 2 | 2016 | 153 | 0.140 |
Why?
|
| Toothbrushing | 1 | 1998 | 3 | 0.140 |
Why?
|
| Dental Care for Aged | 1 | 1998 | 2 | 0.140 |
Why?
|
| Blood Pressure | 6 | 2015 | 900 | 0.140 |
Why?
|
| Albuminuria | 2 | 2016 | 52 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2014 | 723 | 0.130 |
Why?
|
| Psychometrics | 2 | 2017 | 355 | 0.130 |
Why?
|
| Hypoglycemic Agents | 4 | 2006 | 408 | 0.130 |
Why?
|
| Life Expectancy | 3 | 2008 | 93 | 0.130 |
Why?
|
| Urban Health Services | 2 | 2010 | 44 | 0.130 |
Why?
|
| Local Government | 1 | 2017 | 6 | 0.130 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 25 | 0.130 |
Why?
|
| Patient Admission | 1 | 1998 | 120 | 0.130 |
Why?
|
| Linear Models | 3 | 2013 | 422 | 0.130 |
Why?
|
| Monte Carlo Method | 3 | 2025 | 194 | 0.130 |
Why?
|
| Transgender Persons | 1 | 2019 | 120 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 4 | 2008 | 1090 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 430 | 0.130 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 31 | 0.130 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 11 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2001 | 419 | 0.120 |
Why?
|
| Financing, Personal | 1 | 2016 | 21 | 0.120 |
Why?
|
| Apoptosis | 1 | 2003 | 1731 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 295 | 0.120 |
Why?
|
| Bone Lengthening | 1 | 1996 | 4 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 40 | 0.120 |
Why?
|
| Micrognathism | 1 | 1996 | 11 | 0.120 |
Why?
|
| Internal Fixators | 1 | 1996 | 29 | 0.120 |
Why?
|
| Osteotomy | 1 | 1996 | 42 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 80 | 0.120 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 1996 | 21 | 0.120 |
Why?
|
| Death | 1 | 1996 | 97 | 0.110 |
Why?
|
| Risk Factors | 8 | 2020 | 6120 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 463 | 0.110 |
Why?
|
| Asthma | 2 | 2017 | 1059 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 178 | 0.110 |
Why?
|
| Hospitals, University | 4 | 2001 | 192 | 0.110 |
Why?
|
| Early Medical Intervention | 1 | 2015 | 21 | 0.110 |
Why?
|
| Risk Assessment | 5 | 2014 | 2528 | 0.110 |
Why?
|
| Retrospective Studies | 8 | 2015 | 10719 | 0.110 |
Why?
|
| Time Factors | 3 | 2019 | 5524 | 0.110 |
Why?
|
| Rural Health Services | 1 | 2014 | 16 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 860 | 0.110 |
Why?
|
| Critical Care | 1 | 2018 | 474 | 0.110 |
Why?
|
| Nursing Methodology Research | 2 | 2007 | 11 | 0.110 |
Why?
|
| Chest Pain | 1 | 1994 | 44 | 0.110 |
Why?
|
| Mental Health | 3 | 2022 | 209 | 0.110 |
Why?
|
| Creatinine | 1 | 2015 | 303 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2016 | 240 | 0.100 |
Why?
|
| Insurance, Health, Reimbursement | 3 | 2000 | 56 | 0.100 |
Why?
|
| Physician Incentive Plans | 1 | 2014 | 16 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 1235 | 0.100 |
Why?
|
| Cell Phone | 1 | 2014 | 39 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 303 | 0.100 |
Why?
|
| Resource Allocation | 2 | 2008 | 64 | 0.100 |
Why?
|
| Cost Savings | 1 | 2014 | 67 | 0.100 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 106 | 0.100 |
Why?
|
| Family | 2 | 2014 | 327 | 0.100 |
Why?
|
| Urea | 1 | 2013 | 54 | 0.100 |
Why?
|
| Personnel Turnover | 1 | 2013 | 11 | 0.100 |
Why?
|
| Disease Progression | 2 | 2015 | 1586 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1994 | 235 | 0.090 |
Why?
|
| Adenoidectomy | 1 | 2012 | 25 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2016 | 575 | 0.090 |
Why?
|
| Withholding Treatment | 2 | 2008 | 127 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2013 | 194 | 0.090 |
Why?
|
| Financing, Government | 1 | 2012 | 26 | 0.090 |
Why?
|
| Tonsillectomy | 1 | 2012 | 32 | 0.090 |
Why?
|
| Diabetic Retinopathy | 3 | 2006 | 79 | 0.090 |
Why?
|
| Melanoma | 1 | 2016 | 511 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2021 | 1104 | 0.090 |
Why?
|
| Career Choice | 2 | 2007 | 157 | 0.090 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2012 | 82 | 0.090 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2011 | 15 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 906 | 0.090 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2011 | 17 | 0.090 |
Why?
|
| Mentors | 2 | 2005 | 99 | 0.080 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2011 | 6 | 0.080 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 9 | 0.080 |
Why?
|
| Sympathetic Nervous System | 3 | 2000 | 100 | 0.080 |
Why?
|
| Health Surveys | 2 | 2003 | 251 | 0.080 |
Why?
|
| Demography | 2 | 2013 | 192 | 0.080 |
Why?
|
| Pain | 1 | 2013 | 415 | 0.080 |
Why?
|
| Nephrology | 1 | 2011 | 47 | 0.080 |
Why?
|
| Oregon | 3 | 2014 | 25 | 0.080 |
Why?
|
| Colorado | 3 | 2014 | 39 | 0.080 |
Why?
|
| Diabetic Foot | 2 | 2001 | 16 | 0.080 |
Why?
|
| Suicide, Assisted | 2 | 2008 | 37 | 0.080 |
Why?
|
| Telemedicine | 1 | 2014 | 238 | 0.080 |
Why?
|
| Frail Elderly | 2 | 2013 | 96 | 0.080 |
Why?
|
| Schools | 1 | 2011 | 91 | 0.080 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2011 | 65 | 0.080 |
Why?
|
| Heart | 3 | 2000 | 526 | 0.080 |
Why?
|
| Pediatrics | 1 | 2014 | 398 | 0.080 |
Why?
|
| Immunization Programs | 1 | 2009 | 28 | 0.080 |
Why?
|
| Forms and Records Control | 1 | 2009 | 15 | 0.070 |
Why?
|
| Social Values | 2 | 2021 | 44 | 0.070 |
Why?
|
| Self Report | 1 | 2011 | 352 | 0.070 |
Why?
|
| Lobbying | 1 | 2009 | 3 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 2009 | 13 | 0.070 |
Why?
|
| Nutrition Surveys | 3 | 2016 | 130 | 0.070 |
Why?
|
| Risk Management | 1 | 2009 | 43 | 0.070 |
Why?
|
| Schools, Medical | 1 | 2010 | 135 | 0.070 |
Why?
|
| Health Resources | 2 | 2000 | 78 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 79 | 0.070 |
Why?
|
| Training Support | 3 | 2021 | 23 | 0.070 |
Why?
|
| Time Management | 1 | 2008 | 6 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 137 | 0.070 |
Why?
|
| Chronic Pain | 1 | 2011 | 199 | 0.070 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2009 | 29 | 0.070 |
Why?
|
| Ethics, Clinical | 2 | 2007 | 47 | 0.070 |
Why?
|
| Urban Health | 1 | 2008 | 54 | 0.070 |
Why?
|
| Personnel Management | 1 | 2008 | 7 | 0.070 |
Why?
|
| Blood Cells | 1 | 2008 | 32 | 0.070 |
Why?
|
| Mandatory Reporting | 1 | 2007 | 8 | 0.070 |
Why?
|
| Evidence-Based Medicine | 3 | 2006 | 464 | 0.070 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2007 | 2 | 0.070 |
Why?
|
| Medical Staff | 1 | 2007 | 8 | 0.070 |
Why?
|
| Helping Behavior | 1 | 2007 | 8 | 0.070 |
Why?
|
| Nursing Assessment | 1 | 2007 | 20 | 0.070 |
Why?
|
| Nursing Staff | 1 | 2007 | 10 | 0.070 |
Why?
|
| Pigmentation Disorders | 1 | 2007 | 13 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 1149 | 0.070 |
Why?
|
| Nutritional Status | 1 | 2007 | 81 | 0.070 |
Why?
|
| Financial Management | 1 | 2007 | 21 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 129 | 0.060 |
Why?
|
| Nurse Practitioners | 1 | 2007 | 36 | 0.060 |
Why?
|
| Mass Screening | 3 | 2007 | 736 | 0.060 |
Why?
|
| Refusal to Treat | 1 | 2007 | 27 | 0.060 |
Why?
|
| Carotid Stenosis | 1 | 2008 | 115 | 0.060 |
Why?
|
| Perception | 1 | 2008 | 187 | 0.060 |
Why?
|
| Educational Status | 1 | 2007 | 203 | 0.060 |
Why?
|
| Sex Factors | 4 | 2011 | 1135 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 26 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2007 | 598 | 0.060 |
Why?
|
| HIV Infections | 1 | 2016 | 1001 | 0.060 |
Why?
|
| Weight Loss | 2 | 2006 | 241 | 0.060 |
Why?
|
| Community Participation | 2 | 2003 | 40 | 0.060 |
Why?
|
| Health Services, Indigenous | 1 | 2025 | 1 | 0.060 |
Why?
|
| Emotions | 1 | 2009 | 386 | 0.060 |
Why?
|
| Canada | 2 | 2018 | 202 | 0.060 |
Why?
|
| Prisons | 1 | 2025 | 16 | 0.060 |
Why?
|
| Social Behavior | 1 | 2008 | 315 | 0.060 |
Why?
|
| Heart Conduction System | 2 | 2000 | 141 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2025 | 93 | 0.060 |
Why?
|
| Idaho | 2 | 2014 | 9 | 0.050 |
Why?
|
| Massachusetts | 2 | 2014 | 37 | 0.050 |
Why?
|
| Life Change Events | 1 | 2005 | 49 | 0.050 |
Why?
|
| Pennsylvania | 2 | 2014 | 107 | 0.050 |
Why?
|
| Dementia | 2 | 2011 | 224 | 0.050 |
Why?
|
| Illinois | 1 | 2006 | 517 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2025 | 51 | 0.050 |
Why?
|
| Insurance Claim Review | 1 | 2024 | 50 | 0.050 |
Why?
|
| Texas | 1 | 2024 | 135 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 2409 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2025 | 478 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 635 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2006 | 1118 | 0.050 |
Why?
|
| Community Health Planning | 1 | 2003 | 22 | 0.050 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2025 | 216 | 0.050 |
Why?
|
| Professional Autonomy | 2 | 2008 | 41 | 0.050 |
Why?
|
| Organizational Case Studies | 2 | 2014 | 25 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2003 | 42 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2003 | 42 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 122 | 0.050 |
Why?
|
| DNA | 2 | 2003 | 1270 | 0.050 |
Why?
|
| China | 1 | 2003 | 268 | 0.050 |
Why?
|
| Cell Count | 1 | 2003 | 195 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 1 | 2003 | 74 | 0.050 |
Why?
|
| Knowledge | 1 | 2022 | 30 | 0.050 |
Why?
|
| Methotrexate | 1 | 2003 | 226 | 0.050 |
Why?
|
| Terminal Care | 4 | 2009 | 147 | 0.040 |
Why?
|
| Health Maintenance Organizations | 1 | 1982 | 18 | 0.040 |
Why?
|
| Universities | 2 | 2015 | 162 | 0.040 |
Why?
|
| Marketing of Health Services | 1 | 1982 | 15 | 0.040 |
Why?
|
| Personal Autonomy | 2 | 2007 | 125 | 0.040 |
Why?
|
| Hospitals, Urban | 2 | 2001 | 64 | 0.040 |
Why?
|
| Health Benefit Plans, Employee | 1 | 1982 | 14 | 0.040 |
Why?
|
| Industry | 1 | 1982 | 20 | 0.040 |
Why?
|
| Health Education | 1 | 2002 | 109 | 0.040 |
Why?
|
| Clinical Medicine | 1 | 2001 | 26 | 0.040 |
Why?
|
| Bone Density | 1 | 2003 | 246 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 284 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2013 | 397 | 0.040 |
Why?
|
| Women's Health | 1 | 2022 | 113 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 115 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 227 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2000 | 24 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2001 | 75 | 0.040 |
Why?
|
| Anabolic Agents | 1 | 2000 | 5 | 0.040 |
Why?
|
| Incidence | 2 | 2007 | 1741 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1999 | 18 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 3969 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 52 | 0.040 |
Why?
|
| Insulin | 2 | 2006 | 1216 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2024 | 1148 | 0.040 |
Why?
|
| Health Services | 1 | 2000 | 54 | 0.040 |
Why?
|
| Sports | 1 | 2000 | 41 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2003 | 759 | 0.040 |
Why?
|
| Cause of Death | 2 | 2016 | 277 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 1999 | 45 | 0.040 |
Why?
|
| Photography | 1 | 2019 | 43 | 0.040 |
Why?
|
| Accidental Falls | 1 | 1999 | 48 | 0.040 |
Why?
|
| Drug Interactions | 1 | 1999 | 238 | 0.040 |
Why?
|
| Tooth Avulsion | 1 | 1999 | 1 | 0.040 |
Why?
|
| Crown Lengthening | 1 | 1999 | 1 | 0.040 |
Why?
|
| Mandibular Diseases | 1 | 1999 | 17 | 0.040 |
Why?
|
| Alveolar Bone Loss | 1 | 1999 | 21 | 0.040 |
Why?
|
| Morbidity | 1 | 1999 | 162 | 0.040 |
Why?
|
| External Fixators | 1 | 1999 | 20 | 0.040 |
Why?
|
| Maxilla | 1 | 1999 | 20 | 0.040 |
Why?
|
| Dental Implants | 1 | 1999 | 12 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2002 | 1525 | 0.040 |
Why?
|
| Dental Plaque Index | 1 | 1998 | 3 | 0.040 |
Why?
|
| Sonication | 1 | 1998 | 5 | 0.040 |
Why?
|
| Dental Care for Chronically Ill | 1 | 1998 | 4 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 95 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 975 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2002 | 653 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2002 | 378 | 0.030 |
Why?
|
| Boston | 1 | 1998 | 42 | 0.030 |
Why?
|
| Grounded Theory | 1 | 2018 | 7 | 0.030 |
Why?
|
| Panic Disorder | 1 | 1998 | 21 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1998 | 175 | 0.030 |
Why?
|
| Mandible | 1 | 1999 | 126 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 1003 | 0.030 |
Why?
|
| Heart Rate | 2 | 1997 | 528 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 119 | 0.030 |
Why?
|
| Persons | 1 | 1997 | 6 | 0.030 |
Why?
|
| Economic Competition | 1 | 1997 | 12 | 0.030 |
Why?
|
| Ethics, Institutional | 1 | 1997 | 9 | 0.030 |
Why?
|
| Survival Rate | 2 | 2002 | 2019 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1997 | 18 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 87 | 0.030 |
Why?
|
| Nursing Homes | 1 | 1998 | 108 | 0.030 |
Why?
|
| Electrocardiography | 3 | 1994 | 522 | 0.030 |
Why?
|
| Politics | 1 | 1997 | 53 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1997 | 56 | 0.030 |
Why?
|
| Uncertainty | 1 | 1997 | 79 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 402 | 0.030 |
Why?
|
| Body Surface Potential Mapping | 1 | 1996 | 34 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2017 | 132 | 0.030 |
Why?
|
| Caregivers | 1 | 1998 | 194 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 309 | 0.030 |
Why?
|
| Internet | 2 | 2011 | 352 | 0.030 |
Why?
|
| Microstomia | 1 | 1996 | 1 | 0.030 |
Why?
|
| Goldenhar Syndrome | 1 | 1996 | 2 | 0.030 |
Why?
|
| Acrocephalosyndactylia | 1 | 1996 | 6 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 1997 | 111 | 0.030 |
Why?
|
| Heart Atria | 1 | 1997 | 250 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 44 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3562 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1301 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 1995 | 12 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 18 | 0.030 |
Why?
|
| Endothelins | 1 | 1995 | 26 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2002 | 264 | 0.030 |
Why?
|
| Health Facility Size | 1 | 2015 | 12 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 23 | 0.030 |
Why?
|
| Risk | 1 | 1996 | 659 | 0.030 |
Why?
|
| Medical Audit | 1 | 1994 | 43 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 60 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 1994 | 39 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 1996 | 180 | 0.030 |
Why?
|
| Federal Government | 1 | 2014 | 28 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 1994 | 194 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 1997 | 524 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 162 | 0.030 |
Why?
|
| Osteogenesis | 1 | 1996 | 274 | 0.030 |
Why?
|
| Neurons, Efferent | 1 | 1993 | 7 | 0.030 |
Why?
|
| Recurrence | 1 | 1997 | 1235 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 1934 | 0.030 |
Why?
|
| Prognosis | 2 | 2002 | 4041 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 1997 | 377 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 247 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 3221 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1997 | 404 | 0.020 |
Why?
|
| California | 1 | 2013 | 162 | 0.020 |
Why?
|
| New South Wales | 1 | 2012 | 3 | 0.020 |
Why?
|
| Vaccination | 1 | 2015 | 317 | 0.020 |
Why?
|
| Acridines | 1 | 1992 | 4 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 1992 | 32 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 262 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 1992 | 95 | 0.020 |
Why?
|
| Mexiletine | 1 | 1992 | 3 | 0.020 |
Why?
|
| Quinidine | 1 | 1992 | 12 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2012 | 43 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 1997 | 455 | 0.020 |
Why?
|
| Lidocaine | 1 | 1992 | 62 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2012 | 106 | 0.020 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 50 | 0.020 |
Why?
|
| Swine | 3 | 1997 | 588 | 0.020 |
Why?
|
| Professional Practice | 1 | 2011 | 43 | 0.020 |
Why?
|
| Gene Expression | 1 | 1995 | 1313 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 118 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 124 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 1991 | 23 | 0.020 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1991 | 21 | 0.020 |
Why?
|
| Translating | 1 | 2010 | 17 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1991 | 37 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2012 | 133 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 51 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1973 | 0.020 |
Why?
|
| New York City | 1 | 2010 | 74 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2012 | 155 | 0.020 |
Why?
|
| Eligibility Determination | 1 | 2010 | 40 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 527 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1975 | 0.020 |
Why?
|
| Hypokalemia | 1 | 2009 | 21 | 0.020 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2009 | 20 | 0.020 |
Why?
|
| Technetium Tc 99m Sestamibi | 2 | 2000 | 14 | 0.020 |
Why?
|
| Infant | 1 | 1996 | 3259 | 0.020 |
Why?
|
| Diuretics | 1 | 2009 | 79 | 0.020 |
Why?
|
| American Heart Association | 1 | 2009 | 112 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 134 | 0.020 |
Why?
|
| Employee Incentive Plans | 1 | 2008 | 4 | 0.020 |
Why?
|
| Personnel Loyalty | 1 | 2008 | 4 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2000 | 389 | 0.020 |
Why?
|
| Right to Die | 1 | 2008 | 12 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2008 | 70 | 0.020 |
Why?
|
| Religion and Psychology | 1 | 2008 | 16 | 0.020 |
Why?
|
| Attitude to Death | 1 | 2008 | 31 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2007 | 75 | 0.020 |
Why?
|
| Staff Development | 1 | 2008 | 26 | 0.020 |
Why?
|
| Cost Allocation | 1 | 2007 | 5 | 0.020 |
Why?
|
| Advance Directives | 1 | 2008 | 64 | 0.020 |
Why?
|
| Registries | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 312 | 0.020 |
Why?
|
| Radiopharmaceuticals | 2 | 2000 | 214 | 0.020 |
Why?
|
| Life Support Care | 1 | 2008 | 55 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1997 | 2640 | 0.020 |
Why?
|
| Resuscitation Orders | 1 | 2008 | 65 | 0.020 |
Why?
|
| Policy Making | 1 | 2007 | 63 | 0.020 |
Why?
|
| Paternalism | 1 | 2007 | 24 | 0.020 |
Why?
|
| Siblings | 1 | 2007 | 110 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 837 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 301 | 0.020 |
Why?
|
| Workload | 1 | 2008 | 129 | 0.020 |
Why?
|
| Abortion, Legal | 1 | 2007 | 30 | 0.020 |
Why?
|
| Bioethical Issues | 1 | 2007 | 39 | 0.020 |
Why?
|
| Stellate Ganglion | 2 | 2000 | 4 | 0.020 |
Why?
|
| Judaism | 1 | 2006 | 5 | 0.020 |
Why?
|
| Protestantism | 1 | 2006 | 11 | 0.020 |
Why?
|
| Animals | 8 | 2000 | 28471 | 0.010 |
Why?
|
| Physician's Role | 1 | 2008 | 176 | 0.010 |
Why?
|
| Diabetic Neuropathies | 1 | 2006 | 42 | 0.010 |
Why?
|
| Contraception | 1 | 2007 | 102 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 2000 | 344 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2006 | 92 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2008 | 503 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 3193 | 0.010 |
Why?
|
| Cognition | 1 | 2009 | 654 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 138 | 0.010 |
Why?
|
| Biomarkers | 1 | 2011 | 1977 | 0.010 |
Why?
|
| Electrodes | 2 | 1996 | 99 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2005 | 191 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2004 | 238 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2007 | 477 | 0.010 |
Why?
|
| Psychological Theory | 1 | 2002 | 23 | 0.010 |
Why?
|
| Echocardiography | 2 | 1997 | 773 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2003 | 122 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1995 | 945 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2002 | 64 | 0.010 |
Why?
|
| Methods | 1 | 1982 | 135 | 0.010 |
Why?
|
| Dogs | 2 | 1993 | 636 | 0.010 |
Why?
|
| Causality | 1 | 2002 | 82 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1992 | 2348 | 0.010 |
Why?
|
| Awareness | 1 | 1982 | 90 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2003 | 193 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 437 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1982 | 230 | 0.010 |
Why?
|
| Attitude | 1 | 1982 | 131 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2002 | 387 | 0.010 |
Why?
|
| Trinidad and Tobago | 1 | 2000 | 4 | 0.010 |
Why?
|
| Sclerosing Solutions | 1 | 2000 | 8 | 0.010 |
Why?
|
| Autoradiography | 1 | 2000 | 50 | 0.010 |
Why?
|
| Phenol | 1 | 2000 | 7 | 0.010 |
Why?
|
| Weight Lifting | 1 | 2000 | 9 | 0.010 |
Why?
|
| Denervation | 1 | 2000 | 25 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2000 | 20 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2002 | 377 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2002 | 1024 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 715 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2000 | 167 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 645 | 0.010 |
Why?
|
| Action Potentials | 2 | 1993 | 604 | 0.010 |
Why?
|
| Rabbits | 1 | 2000 | 579 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 610 | 0.010 |
Why?
|
| Perfusion | 1 | 2000 | 269 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1999 | 238 | 0.010 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 1995 | 11 | 0.010 |
Why?
|
| Genes, fos | 1 | 1995 | 24 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1995 | 43 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 219 | 0.010 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1993 | 5 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 1549 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1993 | 183 | 0.010 |
Why?
|
| Stroke | 1 | 2003 | 1140 | 0.010 |
Why?
|
| Pericardium | 1 | 1993 | 71 | 0.010 |
Why?
|
| Leukemia P388 | 1 | 1992 | 3 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 1079 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1996 | 741 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 1995 | 515 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1992 | 86 | 0.010 |
Why?
|
| Sodium Channels | 1 | 1992 | 130 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 306 | 0.010 |
Why?
|
| Heart Block | 1 | 1991 | 34 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 1283 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 1026 | 0.010 |
Why?
|
| Kidney | 1 | 1995 | 1114 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1995 | 2845 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 2528 | 0.000 |
Why?
|
| Cell Survival | 1 | 1992 | 1012 | 0.000 |
Why?
|
| Equipment Design | 1 | 1991 | 423 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 2041 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 4051 | 0.000 |
Why?
|
| Biomarkers, Tumor | 1 | 1997 | 1722 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1995 | 3563 | 0.000 |
Why?
|